132 related articles for article (PubMed ID: 29600974)
1. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells.
Boroday NV; Chekhun VF
Exp Oncol; 2018 Mar; 40(1):42-47. PubMed ID: 29600974
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.
Yushko LA; Sarnatskaya VV; Sakhno LA; Hudenko NV; Paziuk LM; Maslenny VN; Melnyk VO; Nikolaev VG
Exp Oncol; 2021 Mar; 43(1):21-25. PubMed ID: 33785723
[TBL] [Abstract][Full Text] [Related]
3. Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.
Sarnatskaya VV; Yushko LA; Prokopenko IV; Hudenko NV; Maslenny VN; Paziuk LM; Bubnovskaya LN; Nikolaev VG
Exp Oncol; 2020 Mar; 42(1):40-45. PubMed ID: 32231185
[TBL] [Abstract][Full Text] [Related]
4. METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPE.
Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich II; Shvets YV; Lukianova NY; Todor IM; Demash DV; Pavlova AA; Naleskina LA
Ukr Biochem J; 2015; 87(2):103-12. PubMed ID: 26255344
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs.
Yalovenko TM; Todor IM; Lukianova NY; Chekhun VF
Exp Oncol; 2016 Jun; 38(2):84-8. PubMed ID: 27356575
[TBL] [Abstract][Full Text] [Related]
6. Effects induced by a 50 Hz electromagnetic field and doxorubicin on Walker-256 carcinosarcoma growth and hepatic redox state in rats.
Orel VE; Krotevych M; Dasyukevich O; Rykhalskyi O; Syvak L; Tsvir H; Tsvir D; Garmanchuk L; Orel VВ; Sheina I; Rybka V; Shults NV; Suzuki YJ; Gychka SG
Electromagn Biol Med; 2021 Oct; 40(4):475-487. PubMed ID: 34392747
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin.
Todor IN; Lukyanova NY; Shvets YV; Lozovska YV; Chekhun VF
Exp Oncol; 2015 Mar; 37(1):19-22. PubMed ID: 25804226
[TBL] [Abstract][Full Text] [Related]
8. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents.
Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich LI; Shvets YV; Lukyanova NY; Todor IM; Tregubova NA; Naleskina LA
Ukr Biochem J; 2016; 88(1):99-108. PubMed ID: 29227592
[TBL] [Abstract][Full Text] [Related]
9. Blood and mast cell histamine levels in magnesium-deficient rats.
Kraeuter SL; Schwartz R
J Nutr; 1980 May; 110(5):851-8. PubMed ID: 6445415
[TBL] [Abstract][Full Text] [Related]
10. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
Desai PB; Duan J; Sridhar R; Damle BD
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
[TBL] [Abstract][Full Text] [Related]
11. Regression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.
Khegay II; Ivanova LN
Biochem Genet; 2015 Apr; 53(1-3):1-7. PubMed ID: 25854851
[TBL] [Abstract][Full Text] [Related]
12. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
[TBL] [Abstract][Full Text] [Related]
13. The relationship between RANTES and mast cells recruitment in the surroundings of intrahepatic implanted tumors.
Ruan Y; Guan Y; Wu Z; Zhang Z; Zheng C
Clin Lab; 2003; 49(1-2):65-9. PubMed ID: 12593477
[TBL] [Abstract][Full Text] [Related]
14. [Effect of vasopressin gene expression on the growth of Walker 256 carcinosarcoma in rats].
Khegaĭ II; Popova NA; Ivanova LN
Genetika; 2006 Jul; 42(7):993-5. PubMed ID: 16915932
[TBL] [Abstract][Full Text] [Related]
15. Total proteolytic activity and content of the main proteinase inhibitors in blood plasma of rats bearing doxorubicin-sensitive and doxorubicin-resistant Guerin carcinoma.
Chekhun VF; Kovtonyuk OV; Todor IN; Kulik GI; Tryndiak VP
Exp Oncol; 2004 Sep; 26(3):232-5. PubMed ID: 15494693
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal dependency of Walker 256 carcinosarcoma growing in rats].
Khegaĭ II
Ross Fiziol Zh Im I M Sechenova; 2008 Nov; 94(11):1335-9. PubMed ID: 19140311
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
[TBL] [Abstract][Full Text] [Related]
18. Histamine formation in rats bearing the Walker mammary carcinosarcoma.
Johnston M
Experientia; 1967 Feb; 23(2):152-4. PubMed ID: 6032118
[No Abstract] [Full Text] [Related]
19. BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITE.
Todor IN; Lukianova NY; Primin MA; Nedayvoda IV; Chekhun VF
Exp Oncol; 2022 Dec; 44(4):320-323. PubMed ID: 36811536
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma.
Belova OB; Vinnichuk UD; Shlakhovenko VA; Berezhnaya NM
Exp Oncol; 2007 Dec; 29(4):272-6. PubMed ID: 18199982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]